These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 29338289)
21. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review. Siefried KJ; Acheson LS; Lintzeris N; Ezard N CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696 [TBL] [Abstract][Full Text] [Related]
22. Impulsivity and positive psychotic symptoms influence hostility in methamphetamine users. Lapworth K; Dawe S; Davis P; Kavanagh D; Young R; Saunders J Addict Behav; 2009 Apr; 34(4):380-5. PubMed ID: 19097704 [TBL] [Abstract][Full Text] [Related]
23. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand. Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802 [TBL] [Abstract][Full Text] [Related]
24. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders. McKetin R; Baker AL; Dawe S; Voce A; Lubman DI Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630 [TBL] [Abstract][Full Text] [Related]
25. A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence. Alexander PD; Gicas KM; Willi TS; Kim CN; Boyeva V; Procyshyn RM; Smith GN; Thornton AE; Panenka WJ; Jones AA; Vila-Rodriguez F; Lang DJ; William MacEwan G; Honer WG; Barr AM Psychopharmacology (Berl); 2017 May; 234(9-10):1535-1547. PubMed ID: 28190084 [TBL] [Abstract][Full Text] [Related]
27. Serotonin 6 receptor gene is associated with methamphetamine-induced psychosis in a Japanese population. Kishi T; Fukuo Y; Okochi T; Kitajima T; Kawashima K; Naitoh H; Ujike H; Inada T; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N Drug Alcohol Depend; 2011 Jan; 113(1):1-7. PubMed ID: 20705401 [TBL] [Abstract][Full Text] [Related]
28. Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis. Iamjan SA; Thanoi S; Watiktinkorn P; Reynolds GP; Nudmamud-Thanoi S J Psychopharmacol; 2018 Mar; 32(3):309-315. PubMed ID: 29338492 [TBL] [Abstract][Full Text] [Related]
29. Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects. Dong H; Yang C; Shen Y; Liu L; Liu M; Hao W Am J Drug Alcohol Abuse; 2019; 45(3):276-284. PubMed ID: 30640573 [TBL] [Abstract][Full Text] [Related]
30. Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population. Lappin JM; Roxburgh A; Kaye S; Chalmers J; Sara G; Dobbins T; Burns L; Farrell M Int J Drug Policy; 2016 Dec; 38():16-20. PubMed ID: 27842249 [TBL] [Abstract][Full Text] [Related]
31. A review of the clinical pharmacology of methamphetamine. Cruickshank CC; Dyer KR Addiction; 2009 Jul; 104(7):1085-99. PubMed ID: 19426289 [TBL] [Abstract][Full Text] [Related]
32. Clinical features of inpatients with methamphetamine-induced psychosis. Fasihpour B; Molavi S; Shariat SV J Ment Health; 2013 Aug; 22(4):341-9. PubMed ID: 23323572 [TBL] [Abstract][Full Text] [Related]
33. Health outcomes associated with methamphetamine use among young people: a systematic review. Marshall BD; Werb D Addiction; 2010 Jun; 105(6):991-1002. PubMed ID: 20659059 [TBL] [Abstract][Full Text] [Related]
34. Methamphetamine psychosis: insights from the past. McKetin R Addiction; 2018 Aug; 113(8):1522-1527. PubMed ID: 29516555 [TBL] [Abstract][Full Text] [Related]
35. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study. Okada N; Takahashi K; Nishimura Y; Koike S; Ishii-Takahashi A; Sakakibara E; Satomura Y; Kinoshita A; Takizawa R; Kawasaki S; Nakakita M; Ohtani T; Okazaki Y; Kasai K Addict Biol; 2016 Mar; 21(2):489-503. PubMed ID: 25619621 [TBL] [Abstract][Full Text] [Related]
36. A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis Voce A; Calabria B; Burns R; Castle D; McKetin R Subst Use Misuse; 2019; 54(4):549-559. PubMed ID: 30693832 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis. Bhatt M; Zielinski L; Baker-Beal L; Bhatnagar N; Mouravska N; Laplante P; Worster A; Thabane L; Samaan Z Syst Rev; 2016 Nov; 5(1):189. PubMed ID: 27842569 [TBL] [Abstract][Full Text] [Related]
38. Clinical Course of Methamphetamine-Induced Psychotic Disorder in a 3-Month Follow-Up. Javadian S; Shabani A; Shariat SV Prim Care Companion CNS Disord; 2016 Nov; 18(6):. PubMed ID: 27907276 [TBL] [Abstract][Full Text] [Related]
39. Hostility among methamphetamine users experiencing psychotic symptoms. McKetin R; McLaren J; Lubman DI; Hides L Am J Addict; 2008; 17(3):235-40. PubMed ID: 18464001 [TBL] [Abstract][Full Text] [Related]
40. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Chen CK; Lin SK; Sham PC; Ball D; Loh EW; Hsiao CC; Chiang YL; Ree SC; Lee CH; Murray RM Psychol Med; 2003 Nov; 33(8):1407-14. PubMed ID: 14672249 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]